Biodegradation of solid lipid nanoparticles as a function of lipase incubation time

International Journal of Pharmaceutics

Volumn 144, Issue 1, 1996, Pages 115-121

  Müller, Rainer H ^a   Rühl, Dörte ^a   Runge, Stephan A ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Biodegradation; Colipase; Free fatty acids; Lipase; Solid lipid nanoparticles; Surfactant

Indexed keywords

COLIPASE; FATTY ACID; NANOPARTICLE; SURFACTANT; TRIACYLGLYCEROL LIPASE;

ARTICLE; BIODEGRADATION; ENZYME DEGRADATION; PRIORITY JOURNAL; TURBIDITY;

EID: 0030598260     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04731-X     Document Type: Article

References (26)

1. Amselem, S., Domb, A.J. and Avling, C.R., Lipospheres as a vaccine carrier system: effects of size, charge, and phospholipid composition. Vaccine Res., 1(4) (1992) 383-395.
2. Blunk, T., Plasmaproteinadsorption auf kolloidalen Arzneistoffträgern. PhD Thesis, University of Kiel, 1994.
3. Blunk, T., Hochstrasser, D.F., Sanchez, J.-C., Müller, B.W. and Müller, R.H., Colloidal for intravenous drug targeting: plasma protein adsorption patters on surface-modified latex particles evaluated by 2-D polyacrylamide gel electrophoresis. Electrophoresis, 14 (1993) 1382-1387.
4. Boltri, L., Canal, T., Esposito, P. and Carli, F., VectorPharma International S.p.A., Trieste Italy, Relevant factors affecting the formulation and growth of lipid nanospheres suspensions. Eur. J. Pharm. Biopharm., 41(1) (1995) 70-75.
5. Borgström, B., On the interactions between pancreatic lipase and colipase and the substrate, and the importance of bile salts. J. Lipid Res., 16 (1975) 411-417.
6. Gasco, M.R. and Morel, S., Lipospheres from microemulsions. II Farmaco, 45 (1990) 1127-1128.
7. Hofmann, A.F., Lipase, colipase; ainphipathic dietry proteins, and bile acids: new interactions at an old interface. Gastroenterlogy, 75 (1978) 530-532.
8. Hofmann, A.F. and Borgström, B., Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc., 21 (1962) 43-50.
9. Keller, M.P., Buri, P. and Charollais, E., Importance des lipases du tractus digestif pour l'hydrolyse des exipients lipidiques et l'enzymothérapie de substitution. Pharm. Acta Helv., 67 (2) (1992).
10. Lairon, D., Nalbone, G., Lafont, H., Leonardi, J., Domingo, N., Hauton, J. C. and Verger, R., Possible roles of bile lipids and colipase in lipase adsorption. Biochemistry, 17(24) (1978) 5263-5269.
11. Lairon, D., Nalbone, G., Lafont, H., Leonardi, J., Vigne, J.L., Chabret, C., Hauton, J.C. and Verger, R., Effects of bile lipids on the adsorption and activity of pancreatic lipase on triglycerol emulsions, Biochim, Biophys. Acta, 618 (1980) 119-128.
12. Maaßen, S., Schwarz, C., Mehnert, W. and Müller, R.H., Solid lipid nanoparticles (SLN) formulation for human use: interaction with human granulocytes. J. Control. Release, (1996) submitted.
13. Momsen, W.E. and Brockman, H.L., Effects of colipase and taurodeoxycholate on the catalytic and physical properties of lipase B at an oil-water interface. J. Biol. Chem., 251 (1976) 378.
14. Müller, R.H., Lherm, C., Herbort, J. and Couvreur, P., In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials, 11 (1990) 590-595.
15. Müller, R.H., Lherm, C., Herbert, J., Blunk, T. and Couvreur, P., Alkylcyanoacrylate drug carrier: I. Physicochemical characterisation of nanoparticles with different alkyl chain length. Int. J. Pharm., 84 (1992) 1-11.
16. Müller, R.H. and Lucks, J.S., German Patent Application P 4131562.6, 1991.
17. Müller, R.H., Mehnert, W., Lucks, J.S., Schwarz, C., zur Mühlen, A., Weyhers, H., Freitas, C. and Rühl, D., Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm., 41(1) (1995) 62-69.
18. Rudt, S. and Müller, R.H., In vitro phagocytosis assay of nano and microparticies by chemiluminescence: II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake. J. Control. Release, 25 (1993) 51-59.
19. Schwarz, C., Mehnert, W., Lucks, J.S. and Müller, R.H., Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterisation and sterilisation. J. Control. Release, 30 (1993) 83-96.
20. Siekmann, B. and Westesen, K., Submikron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett., 1 (1992) 123-126.
21. Wako Chemicals, instruction for NEFA C test, 1993.
22. Wallis, K.H. and Müller, R.H., Comparative measurements of nanoparticle degradation velocity using an accelerated hydrolysis test. Pharm. Ind., 55 (1993) 168-170.
23. Weyhers, H., Preparation and characterisation of solid lipid nanoparticles for drug targeting. PhD Thesis, Free University of Berlin, 1995.
24. Weyhers, H., Lück M., Mehnert W. and Müller, R.H., Solid Lipid Nanoparticles (SLN) for controlled delivery of hydrophilic drugs. 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Budapest, 1995.
25. Wollesen, C., Untersuchungen zur Wirkung des Appetitzüglers Fenfluramin auf die Lipidresorption bei der Ratte. PhD Thesis, University of Kiel, 1981.
26. zur Mühlen, A., Feste Lipid Nanopartikel mit prolongierter Wirkstoffliberation-Herstellung, Langzeitstabilität, Charakterisierung, Freisetzungsverhalten und-Mechanismen. PhD Thesis, Free University of Berlin, 1996.